Oligonucleotide therapies for nonalcoholic steatohepatitis

Nonalcoholic steatohepatitis (NASH) represents a severe disease subtype of nonalcoholic fatty liver disease (NAFLD) that is thought to be highly associated with systemic metabolic abnormalities. It is characterized by a series of substantial liver damage, including hepatocellular steatosis, inflamma...

Descrición completa

Detalles Bibliográficos

Principais autores:	Sixu Li, Feng Xiong, Songbo Zhang, Jinghua Liu, Guangping Gao, Jun Xie, Yi Wang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2024-06-01
Series:	Molecular Therapy: Nucleic Acids
Assuntos:	MT: Oligonucleotides: Therapies and Applications NASH NAFLD RNAi ASO siRNA
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2162253124000714
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!